Prospective use of microvolt T-wave alternans testing to guide primary prevention implantable cardioverter defibrillator therapy

Circulation Journal

Volumn 79, Issue 9, 2015, Pages 1912-1919

  Merchant, Faisal M ^a   Salerno Uriarte, Jorge A ^b   Caravati, Fabrizio ^b   Falcone, Stefania ^b   Molon, Giulio ^c   Marangoni, Daniele ^c   Raczak, Grzegorz ^d   Danilowicz Szymanowicz, Ludmila ^d   Pedretti, Roberto F E ^e   Braga, Simona Sarzi ^e   Ikeda, Takanori ^f   Calo, Leonardo ^g   Martino, Annamaria ^g   Erciyes, Demet ^h   Piancastelli, Maurizio ⁱ   Maury, Philippe ^j   Cohen, Richard J ^k   Armoundas, Antonis A ^l  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Don Calabria   (Italy)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e IRCCS   (Italy)

^f TOHO UNIVERSITY   (Japan)

^g Casilino Clinic   (Italy)

^h FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

ⁱ S Maria della Croci   (Italy)

^j CHU RANGUEIL   (France)

^k Massachusetts Institute of Technology Cambridge   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Implantable cardioverter defibrillator; Microvolt T wave alternans; Primary prevention; Risk stratification; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; MICROVOLT T WAVE ALTERNANS TESTING; MORTALITY; SURVIVAL TIME; TREATMENT PLANNING; ARRHYTHMIAS, CARDIAC; CARDIOVERSION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84940025309     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0253     Document Type: Article

References (22)

1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device- Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/ AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-e408, doi:10.1161/ CIRCUALTIONAHA.108.189742.
2. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. Circ J 2013; 77: 249- 274.
3. Hohnloser SH, Ikeda T, Cohen RJ. Evidence regarding clinical use\ of microvolt T-wave alternans. Heart Rhythm 2009; 6: S36-S44.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
6. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008; 52: 1111-1121.
7. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter- defibrillators. J Am Coll Cardiol 2006; 47: 2493-2497.
8. Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: Results of the ALPHA Study. J Am Coll Cardiol 2007; 50: 1896-1904.
9. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 2007; 49: 50-58.
10. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 2006; 47: 1820-1827.
11. Merchant FM, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Chow T, Chan PS, et al. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. Heart Rhythm 2012; 9: 1256-1264.
12. Hoshida K, Miwa Y, Miyakoshi M, Tsukada T, Yusu S, Yoshino H, et al. Simultaneous assessment of T-wave alternans and heart rate turbulence on holter electrocardiograms as predictors for serious cardiac events in patients after myocardial infarction. Circ J 2013; 77: 432-438.
13. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994; 330: 235-241.
14. Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 2002; 13: 502-512.
15. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009; 2: 16-24.
16. Molon G, Cohen RJ, de Santo T, Costa A, Barbieri E. Clinical use of microvolt T-wave alternans in patients with depressed left ventricular function eligible for ICD implantation: Mortality outcomes after long term follow-up. Int J Cardiol 2013; 168: 3038-3040.
17. Merchant FM, Zheng H, Bigger T, Steinman R, Ikeda T, Pedretti RF, et al. A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification. Am Heart J 2013; 166: 744-752.
18. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, et al. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: An extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2010; 122: 1265-1271.
19. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275-2283.
20. Murakoshi N, Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J 2013; 77: 2419-2431.
21. Stevenson LW. Projecting heart failure into bankruptcy in 2012? Am Heart J 2011; 161: 1007-1011.
22. Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol 2008; 52: 1607-1615.